Bicycle Therapeutics Ltd (BCYC) — Strategic Asset Allocation Index
Bicycle Therapeutics Ltd (BCYC) has a Strategic Asset Allocation Index of 7.3% as of September 2023. Strategic assets (PP&E of $30.20 Million plus long-term investments of $-) total $30.20 Million, measured against net assets of $416.02 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Bicycle Therapeutics Ltd balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Bicycle Therapeutics Ltd Strategic Asset Allocation Index (2016–2022)
This chart shows how Bicycle Therapeutics Ltd's Strategic Asset Allocation Index has evolved across 5 annual periods from 2016 to 2022. As of September 2023, the index stands at 7.3%, representing strategic assets of $30.20 Million against net assets of $416.02 Million USD. For live market cap and overall valuation, see BCYC market cap.
Annual Strategic Asset Allocation Index for Bicycle Therapeutics Ltd (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Bicycle Therapeutics Ltd from 2016 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Bicycle Therapeutics Ltd book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 12.1% | $32.77 Million | $32.77 Million | $- | $270.78 Million | ▲ +7.0 pp |
| 2021 | 5.1% | $17.79 Million | $17.79 Million | $- | $346.25 Million | ▲ +1.4 pp |
| 2020 | 3.8% | $3.61 Million | $3.61 Million | $- | $95.46 Million | ▼ -0.9 pp |
| 2019 | 4.7% | $4.35 Million | $4.35 Million | $- | $93.20 Million | ▼ -1.8 pp |
| 2016 | 6.5% | $519.00K | $519.00K | $0.00 | $8.02 Million | — |